The Global Health Body Sounds Alert Over Critical Lack of Obesity Jabs
Under a tenth of people eligible to benefit from weight-loss injections like Wegovy are able to get them, caution the World Health Organization as it publishes its inaugural recommendations on the medications.
Considering over a billion people worldwide currently living with obesity, it is urging broader and more equitable availability to this class of drugs.
According to estimates, more than two billion will be obese by 2030 unless action is taken.
"The new guidelines recognises that obesity is a chronic disease that can be treated with thorough and ongoing treatment," remarked its chief Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and logistical bottlenecks are major obstacles to broad access to the injections that can aid individuals in losing substantial body mass, explains the organization.
Skinny Jab Scarcity
Even in the current most optimistic outlook, the production of these medications could only cover about 100 million people – under 10% of those who need them, according to the health organization.
The recommendation calls on nations and manufacturers to expand access, via approaches such as voluntary licensing.
Exclusive production rights on a key compound – the main component of a leading brand – is set to lapse in several countries in 2026.
How Weight-Loss Injections Function
These medications mimick a body's own hormone to delay gastric emptying, curb appetite and enhance the sense of being full so individuals consume fewer calories.
Patients commonly start to lose weight within a few weeks of commencing the regular doses.
Studies points to patients may regain a significant portion within a year of halting the medication, when their typical hunger return.
To be above a healthy weight increases your chance for contracting diseases, such as type 2 diabetes, heart disease, stroke, and certain cancers.
Excess weight concerns people in countries worldwide and was responsible for 3.7 million deaths worldwide in 2024, according to the health agency.